Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
株式のランク #30249
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
株価
$1.88
最終同期: 2026-08-18
時価総額
$17.59M
変化(1日)
0.81%
変化(1年)
-92.40%
US
取引 Tvardi Therapeutics, Inc. (TVRD)

カテゴリー

Tvardi Therapeutics, Inc.(TVRD)の株価履歴
終値の最高値: $1.83 (2026-08-01)

終値の最安値: $17.54 (2025-04-01)
Tvardi Therapeutics, Inc. の株価履歴(2025 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 100.99%
2025 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.09%
US
$996.61 51.72%
NL
$115.26 -20.82%
AU
$735.86 6.07%
CH
$1.06K -5.95%
KR